Qualigen Therapeutics News

Qualigen Therapeutics | 424B3: Prospectus

13:52 ET

Qualigen Therapeutics | EFFECT: Others

May 3 06:06 ET

Qualigen Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

May 1 12:36 ET

Qualigen Therapeutics | 8-K: Current report

Apr 16 16:16 ET

Qualigen Therapeutics | 10-K: Annual report

Apr 8 06:07 ET

Qualigen Therapeutics | NT 10-K: Others

Apr 1 14:37 ET

Qualigen Therapeutics | 8-K: Current report

Mar 28 16:10 ET

Qualigen Therapeutics | 8-K: Current report

Feb 27 07:05 ET

Qualigen Therapeutics | 8-K: Current report

Feb 22 16:13 ET

Qualigen Therapeutics | 8-K: Current report

Dec 7, 2023 16:15 ET

Qualigen Therapeutics | 8-K: Current report

Nov 22, 2023 16:30 ET

Qualigen Therapeutics | 8-K: Current report

Nov 14, 2023 17:10 ET

Qualigen Therapeutics: Q3 2023 Earnings Report

Nov 14, 2023 16:54 ET

Qualigen Therapeutics | 8-K: Current report

Nov 8, 2023 14:16 ET

Qualigen Therapeutics | 8-K: Current report

Oct 17, 2023 08:30 ET

Qualigen Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Oct 2, 2023 20:04 ET

Qualigen Therapeutics | 424B3: Prospectus

Sep 29, 2023 16:30 ET

Qualigen Therapeutics | 8-K: Current report

Sep 28, 2023 16:15 ET

Qualigen Therapeutics | EFFECT: Others

Sep 8, 2023 00:15 ET

Qualigen Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Sep 1, 2023 16:15 ET